The burgeoning interest in state-regulated psychedelic therapies, driven by the potential benefits for treating various medical conditions, stands at a critical juncture with federal law and FDA regulations. The evolving landscape, marked by initiatives in states like Oregon and Colorado, reflects a need for careful navigation to avoid conflicts and ensure compliance.
Yesterday, Colombian President Gustavo Petro appeared before the UN Commission on Narcotic Drugs, where he…
Before New Constellations started turning heads with dreamy synth-pop and soft-focus heat, Harlee Case was…
In High Times’ new documentary on Rove, one of cannabis culture’s most enduring rituals gets…
The best weed ads don’t feel like ads anymore. They feel like content built to…
“Do you know why I stopped you this evening?” “No sir, I was going the…
Virginia lawmakers have sent a marijuana resentencing bill to Gov. Abigail Spanberger, opening a path…